The impact of diabetes and osteoarthritis on the occurrence of stroke, acute myocardial infarction, and heart failure among older adults with non-valvular atrial fibrillation in Hawaii: a retrospective observational cohort study

The impact of diabetes and osteoarthritis on the occurrence of stroke, acute myocardial infarction, and heart failure among older adults with non-valvular atrial fibrillation in Hawaii: a retrospective observational cohort study

Abstract Background To date, little is known about cardiovascular disease risks among older adults with non-valvular atrial fibrillation by their association with diabetes and osteoarthritis status, based on longitudinal data with substantial amounts of non-white individuals. The objective of this s...

Full description

Bibliographic Details
Main Authors:	Masako Matsunaga, John J. Chen, Mayumi Jijiwa, Eunjung Lim
Format:	Article
Language:	English
Published:	BMC 2021-06-01
Series:	BMC Public Health
Subjects:	Non-valvular atrial fibrillation Diabetes Osteoarthritis Cardiovascular disease Stroke Myocardial infarction
Online Access:	https://doi.org/10.1186/s12889-021-11247-0

Similar Items

Is There Association Between Changes in eGFR Value and the Risk of Permanent Type of Atrial Fibrillation? - Analysis of Valvular and Non-Valvular Atrial Fibrillation Population
by: Elzbieta Mlodawska, et al.
Published: (2014-12-01)

Current strategies of anticoagulation therapy for patients with non-valvular atrial fibrillation
by: Masahiro Yasaka
Published: (2012-12-01)

Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
by: Athanasios Samaras, et al.
Published: (2021-09-01)

Role of miRNA in the development of atrial fibrillation in patients with valvular heart disease
by: I. V. Abdulyanov, et al.
Published: (2020-11-01)

Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
by: Faye L. Norby, et al.
Published: (2017-09-01)

A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation
by: Luxiang Shang, et al.
Published: (2021-07-01)

The methods of treatment of atrial fibrillation in patients with valvular heart disease
by: O.M. Grytsay, et al.
Published: (2019-03-01)

Increased levels of red cell distribution width is correlated with presence of left atrial stasis in patients with non-valvular atrial fibrillation
by: Adnan Kaya, et al.
Published: (2017-05-01)

Gender-related differences in presentation and treatment of patients with non-valvular atrial fibrillation: results from RAMSES study
by: Volkan Doğan, et al.
Published: (2017-01-01)

Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study
by: Rungroj Krittayaphong, et al.
Published: (2018-08-01)

STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION. WHAT ROCKET AF STUDY RESULTS SAY
by: I. S. Yavelov
Published: (2017-11-01)

Comprehensive analysis of autophagy-related genes and patterns of immune cell infiltration in valvular atrial fibrillation
by: Ao Liu, et al.
Published: (2021-03-01)

Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation
by: Daiki Shimomura, et al.
Published: (2015-08-01)

INTRAOPERATIVE RADIOFREQUENCY AND CRYOABLATION FOR ATRIAL FIBRILLATION IN PATIENTS WITH VALVULAR HEART DISEASE
by: N. Maghamipour N. Safaie
Published: (2007-05-01)

INTRAOPERATIVE RADIOFREQUENCY AND CRYOABLATION FOR ATRIAL FIBRILLATION IN PATIENTS WITH VALVULAR HEART DISEASE
by: N. Maghamipour N. Safaie
Published: (2007-02-01)

Comparing clinical outcomes of NOACs with warfarin on atrial fibrillation with Valvular heart diseases: a meta-analysis
by: Qiyu He, et al.
Published: (2019-05-01)

Use of Novel oral anticoagulants (NOACs) in patients with risk of stroke in non valvular Atrial Fibrillation (AF)
by: Fawad Farooq, et al.
Published: (2017-12-01)

Estimating the cost-effectiveness of treatment for prevention of thromboembolic events in at-risk adults with non-valvular atrial fibrillation
by: Marco Bellone, et al.
Published: (2018-02-01)

Comparison of the Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Yasmin de Souza Lima Bitar, et al.
Published: (2021-09-01)

Budget impact analysis of dabigatran compared with rivaroxaban in the prevention of the thromboembolic risk in patients with non-valvular atrial fibrillation
by: Maria Grazia Celeste, et al.
Published: (2017-11-01)

The relationship between polymorphisms of P-selectin genes and plasma P-selectin concentration with thrombosis in non-valvular atrial fibrillation of Kazakh ethnicity
by: Maerjiaen Bakeyi, et al.
Published: (2020-08-01)

Approaches to anticoagulation therapy selection in patients with non-valvular atrial fibrillation and ischemic heart disease
by: N. A. Koziolova, et al.
Published: (2016-04-01)

Clinical Profile of Atrial Fibrillation in Tertiary Hospital in Central Nepal
by: Sachin Dhungel, et al.
Published: (2017-09-01)

Effect of single intraoperative dose of amiodarone in patients with rheumatic valvular heart disease and atrial fibrillation undergoing valve replacement surgery
by: Selvaraj Thiruvenkadam, et al.
Published: (2009-01-01)

Expression Profiles of Circular RNA in Human Atrial Fibrillation With Valvular Heart Diseases
by: Xiyu Zhu, et al.
Published: (2020-11-01)

Anticoagulation Therapy for Non-valvular Atrial Fibrillation: A Mini-Review
by: Jia Wu, et al.
Published: (2020-07-01)

ATRIAL FIBRILLATION ASSOCIATED WITH MYOCARDIAL INFARCTION OF DIFFERENT LOCALIZATIONS
by: R. Bhattarai, et al.
Published: (2015-09-01)

Pathogenesis and clinical significance of atrial fibrillation in myocardial infarction
by: M. V. Zykov, et al.
Published: (2021-03-01)

Prediction of Recurrent Atrial Tachyarrhythmia After Receiving Atrial Flutter Ablation in Patients With Prior Cardiac Surgery for Valvular Heart Disease
by: Ching-Yao Chou, et al.
Published: (2021-09-01)

Predictions and outcomes of atrial fibrillation in the patients with acute myocardial infarction
by: Vukmirović Mihailo, et al.
Published: (2017-05-01)

Development of a tool to improve the quality of decision making in atrial fibrillation
by: Street Richard L, et al.
Published: (2011-10-01)

Sex Differences in Outcomes among Stroke Survivors with Non-Valvular Atrial Fibrillation in China
by: Zhongping An, et al.
Published: (2017-04-01)

Evaluación del tratamiento de la fibrilación auricular valvular y no valvular y su relación con eventos adversos en pacientes hospitalizados en el servicio de urgencias de un hospital de tercer nivel
by: Angélica María Rojas-Durán, et al.
Published: (2020-11-01)

Features of the myocardial infarction course in patients with a permanent atrial fibrillation.
by: M. I. Yalovenko, et al.
Published: (2018-05-01)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
by: Inki Moon, et al.
Published: (2019-10-01)

Effect of Evidence-Based Pharmacy Care on Satisfaction and Cognition in Patients with Non-Valvular Atrial Fibrillation Taking Rivaroxaban
by: Sun J, et al.
Published: (2021-07-01)

Stroke prevention for non-valvular atrial fibrillation: how to make the right choice of directly acting oral anticoagulants?
by: N. N. Kryukov, et al.
Published: (2019-02-01)

Prognostic impact of atrial fibrillation in patients with acute myocardial infarction
by: Shunta Tateyama, MD, et al.
Published: (2014-12-01)

Comprehensive Use of Routine Clinical Parameters to Identify Patients at Risk of New-Onset Atrial Fibrillation in Acute Myocardial Infarction
by: Monika Raczkowska-Golanko, et al.
Published: (2021-08-01)

Prognostic value of atrial fibrillation in group of patients with myocardial infarction. Long-term observation results
by: M. V Soloveva, et al.
Published: (2021-03-01)